300401.SZ
300401.SZ
CNE100001XX7
GARDEN BIO-CHEM
Loading chart...

Company Profile

Zhejiang Garden Biopharmaceutical Co.,Ltd. engages in the research, development, production and sales of vitamin products and pharmaceuticals in China. The company offers lanolin cholesterol series products, such as cholesterol and feed grade cholesterol; vitamin D3 products, including food additives compound nutrient fortifier SDS, food additives compound nutritional fortifier CO and MO, cholecalciferol, vitamin D3 particles, feed additive vitamin D3 oil, and VD3 resin oil; and 25 HydroxyVitamin D3 Progen, 25 hydroxyvitamin D3, and 25 hydroxyvitamin D3 powder. It also provides refined lanolin comprising anhydrous lanolin, wool oil, wool wax, low chroma ultra pure fat, lanolin alcohol, isopropyl lanolate, lanolinic acid, high acid fat, and wool acid biofuel/wool alcohol biofuel; and vitamin D3 environmental rodenticide. Zhejiang Garden Biopharmaceutical Co.,Ltd. was formerly known as Zhejiang Garden Bio-chemical High-tech Co., Ltd. and changed its name to Zhejiang Garden Biopharmaceutical Co.,Ltd. in April 2023. Zhejiang Garden Biopharmaceutical Co.,Ltd. was founded in 2000 and is based in Dongyang, China.

Related stocks

300267.SZ
300267.SZ • China
ER-KANG
3.36 CNY
1.04B USD 1Y -1.8%
600557.SS
600557.SS • China
JIANGSU KANION PHARMACEUTICAL C
12.4 CNY
1.05B USD 1Y -18.4%
300702.SZ
300702.SZ • China
TIANYU PHARMA
22.18 CNY
1.15B USD 1Y -13.6%
301263.SZ
301263.SZ • China
TEK
19.14 CNY
1.22B USD 1Y -31.8%
000650.SZ
000650.SZ • China
RENHE PHARMACY CO LTD
5.29 CNY
1.11B USD 1Y -12.9%
1681.HK
1681.HK • China
CONSUN PHARMA
14.85 HKD
1.59B USD 1Y -13.6%
600789.SS
600789.SS • China
SHANDONG LUKANG PHARMACEUTICAL
8.28 CNY
1.29B USD 1Y -15.3%
600195.SS
600195.SS • China
CHINA ANIMAL HUSBANDRY INDUSTRY
6.73 CNY
1.03B USD 1Y -6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
44.1% p.a.
Max Drawdown (5Y)
-61.6%
Sharpe Ratio (5Y)
-0.08
Beta Factor
0.48
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Elevated Short-Term Volatility: 3Y volatility (50.8%) is noticeably higher than the 5Y average (44.1%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.3% in the extended horizon.
ende